Cereblon (CRBN) inhibits prostate cancer metastasis by negatively regulating 6-phosphogluconate dehydrogenase (6PGD)

Koushik Guchhait(Gwangju Institute of Science and Technology), Steve K. Cho(Gwangju Institute of Science and Technology)
Oncogene
March 9, 2026
Cited by 0


Related Papers